Canada · Delayed Price · Currency is CAD Ovation Science Statistics
Total Valuation
Ovation Science has a market cap or net worth of CAD 1.73 million. The enterprise value is 2.00 million.
| Market Cap | 1.73M |
| Enterprise Value | 2.00M |
Important Dates
The next estimated earnings date is Thursday, November 27, 2025.
| Earnings Date | Nov 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ovation Science has 38.41 million shares outstanding. The number of shares has increased by 24.62% in one year.
| Current Share Class | 38.21M |
| Shares Outstanding | 38.41M |
| Shares Change (YoY) | +24.62% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 23.06% |
| Owned by Institutions (%) | n/a |
| Float | 26.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 26.71 |
| PB Ratio | -1.34 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 244.21 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.35 |
| EV / Sales | 30.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.61 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -431.39% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 32.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.05 |
| Inventory Turnover | 0.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.50% in the last 52 weeks. The beta is 0.28, so Ovation Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +12.50% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 61.52 |
| Average Volume (20 Days) | 13,417 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ovation Science had revenue of CAD 64,711 and -459,497 in losses. Loss per share was -0.01.
| Revenue | 64,711 |
| Gross Profit | 58,308 |
| Operating Income | -427,182 |
| Pretax Income | -459,497 |
| Net Income | -459,497 |
| EBITDA | -425,633 |
| EBIT | -427,182 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 5,546 in cash and 275,508 in debt, giving a net cash position of -269,962 or -0.01 per share.
| Cash & Cash Equivalents | 5,546 |
| Total Debt | 275,508 |
| Net Cash | -269,962 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -1.29M |
| Book Value Per Share | -0.04 |
| Working Capital | -1.29M |
Cash Flow
| Operating Cash Flow | 7,078 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 90.11% |
| Operating Margin | -660.14% |
| Pretax Margin | -710.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Ovation Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.62% |
| Shareholder Yield | -24.62% |
| Earnings Yield | -26.58% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ovation Science has an Altman Z-Score of -331.13 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -331.13 |
| Piotroski F-Score | 4 |